Mark A. Frye

41.4k citations

449 papers · 20.4k indexed · 5 hit papers · h-index 77

Impact in

Biological Psychiatry top 0.05%
- Tryptophan and brain disorders
Psychiatry and Mental health top 0.02%
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Schizophrenia research and treatment

Papers in

Biological Psychiatry 55
- Tryptophan and brain disorders 55
Psychiatry and Mental health 316
- Bipolar Disorder and Treatment 293
- Electroconvulsive Therapy Studies 82
- Schizophrenia research and treatment 67

Co-authors: Robert M. Post Susan L. McElroy Lori L. Altshuler Gabriele S. Leverich Paul E. Keck Ralph Kupka Willem A. Nolen Trisha Suppes
Journals: Journal of Affective Disorders (58 papers)The Journal of Clinical Psychiatry (38 papers)Bipolar Disorders (35 papers)Biological Psychiatry (29 papers)American Journal of Psychiatry (18 papers)
Partner nations: United States Netherlands Mexico

In The Last Decade

Mark A. Frye

422 papers receiving 19.6k citations

Hit Papers

5 papers align trajectories log scale

Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis 2022 · 122 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Journal of Affective Disorders
2022 World Psychiatry
2017 JAMA Psychiatry
2003 The Journal of Clinical Psychiatry
1989 American Journal of Epidemiology

Peers

Countries citing papers authored by Mark A. Frye

Since Specialization

Citations

This map shows the geographic impact of Mark A. Frye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Frye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Frye more than expected).

Fields of papers citing papers by Mark A. Frye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Frye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Frye. The network helps show where Mark A. Frye may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. Frye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Frye Line = papers co-authored together Mark A. Frye links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prediction of medical admissions after psychiatric inpatient hospitalization in bipolar disorder: a retrospective cohort study Frontiers in Psychiatry ·Alessandro Miola, Michele De Prisco, Valter A. Rodrigues, Nicola Meda, Jiang Yan-yan, Catherine Jia Lin Tian, Nicolás A. Núñez, Michele Fornaro, Marin Veldić, Mark A. Frye, Eduard Vieta, Marco Solmi, Joaquim Raduà, Fabio Sambataro	2024	0
2	Differential serum levels of CACNA1C, circadian rhythm and stress response molecules in subjects with bipolar disorder: Associations with genetic and clinical factors Journal of Affective Disorders ·Mercedes Lilana Dalurzo, Brandon J. Coombes, Vanessa Pazdernik, Barbara Gisabella, W. Ji, Joanna M. Biernacka, Mark A. Frye, Matej Markota, Harry Pantazopoulos	2024	1
3	Association between exposure to antidepressants and stimulants and age at onset of mania or psychosis: A retrospective population-based cohort study European Neuropsychopharmacology ·Alessandro Miola, Diana Garnham, Vanessa Pazdernik, G. Matías Del Río, Carlton H. Green, Manuel Gardea‐Resendez, J. Kreuter, N. W. D., John Bostwick, Alastair J. McKean, Jennifer L. Vande Voort, Ayşegül Özerdem, Mark A. Frye	2024	1
4	Antecedents to first episode psychosis and mania: Comparing the initial prodromes of schizophrenia and bipolar disorder in a retrospective population cohort Journal of Affective Disorders ·Carlton H. Green, Manuel Gardea‐Resendez, Joshua Hiltbrand, Antonia Dibernardo, Brandon J. Coombes, J. Kreuter, N. W. D., John Bostwick, Robert J. Morgan, Ayşegül Özerdem, Mark A. Frye, Alastair J. McKean	2023	14
5	Factors associated with suicide attempts in the antecedent illness trajectory of bipolar disorder and schizophrenia International Journal of Bipolar Disorders ·Alessandro Miola, 福原正人, Carlton H. Green, Nicolás A. Núñez, Diana Garnham, Brandon J. Coombes, G. Matías Del Río, J. Kreuter, N. W. D., John Bostwick, Alastair J. McKean, Ayşegül Özerdem, Mark A. Frye	2023	4
6	Pharmacotherapy exposure as a marker of disease complexity in bipolar disorder: Associations with clinical & genetic risk factors Psychiatry Research ·Megan A. Landriau, Brandon J. Coombes, Richard S. Pendegraft, Ayşegül Özerdem, Susan L. McElroy, Alfredo B. Cuéllar‐Barboza, Miguel L. Prieto, Mark A. Frye, Stacey J. Winham, Joanna M. Biernacka	2023	2
7	Digital Phenotyping for Mood Disorders: Methodology-Oriented Pilot Feasibility Study Journal of Medical Internet Research ·Scott Breitinger, Manuel Gardea‐Resendez, Yinxuan Zhao, J Bahrami, Engelhaupt Erika, 孝晶齋藤, Elena Iakovou, Duncan Martel, Alex J Walker, Richard Wagner, Paula Cristina de Sousa Faria Tischer, Peter P. Zandi, Fernando S. Goes, Mark A. Frye, John Torous	2023	4
8	Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis Molecular Psychiatry ·Gustavo C. Medeiros, Todd D. Gould, P. Wriggers, Julie Nanavati, Michael F. Grunebaum, Nuri B. Farber, Balwinder Singh, Sudhakar Selvaraj, Rodrigo Machado‐Vieira, Eric D. Achtyes, Sagar V. Parikh, Mark A. Frye, Carlos A. Zarate, Fernando S. Goes	2022	46
9	Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania Molecular Psychiatry ·Manuel Gardea‐Resendez, Brandon J. Coombes, Marin Veldić, Susannah J. Tye, Francisco Romo‐Nava, Ayşegül Özerdem, Miguel L. Prieto, Alfredo B. Cuéllar‐Barboza, Nicolás A. Núñez, Balwinder Singh, Richard S. Pendegraft, Alessandro Miola, Susan L. McElroy, Joanna M. Biernacka, Éva Morava, Tamás Kozicz, Mark A. Frye	2022	8
10	TCF7L2 lncRNA: a link between bipolar disorder and body mass index through glucocorticoid signaling Molecular Psychiatry ·Duan Liu, Thanh Thanh L. Nguyen, Huanyao Gao, Woon Yong Park, Daniel C. Kim, Markus Costabiei, Zhenqing Ye, Jeong‐Heon Lee, Brandon J. Coombes, Tamás Ördög, Liewei Wang, Joanna M. Biernacka, Mark A. Frye, Richard M. Weinshilboum	2021	15
11	Dynamic insulin‐stimulated mTOR/GSK3 signaling in peripheral immune cells: Preliminary evidence for an association with lithium response in bipolar disorder Bipolar Disorders ·Susannah J. Tye, Kristin L. Borreggine, Cristina Dopazo, Shari L. Sutor, Alfredo B. Cuéllar‐Barboza, Susan L. McElroy, Joanna M. Biernacka, Mark A. Frye	2021	10
12	Long‐term lithium therapy and risk of chronic kidney disease in bipolar disorder: A historical cohort study Bipolar Disorders ·Mehak Pahwa, Boney Joseph, Nicolás A. Núñez, Gregory D. Jenkins, Colin Colby, Kianoush Kashani, Marin Veldić, Katherine M. Moore, Hannah K. Betcher, Ayşegül Özerdem, Alfredo B. Cuéllar‐Barboza, Susan L. McElroy, Joanna M. Biernacka, Mark A. Frye, Balwinder Singh	2021	21
13	Evening chronotype, disordered eating behavior, and poor dietary habits in bipolar disorder Acta Psychiatrica Scandinavica ·Francisco Romo‐Nava, Thomas J. Blom, Anna I. Guerdjikova, Stacey J. Winham, Alfredo B. Cuéllar‐Barboza, Nicolás A. Núñez, Balwinder Singh, Joanna M. Biernacka, Mark A. Frye, Susan L. McElroy	2020	29
14	Differential Dorsolateral Prefrontal Cortex Proteomic Profiles of Suicide Victims with Mood Disorders Genes ·辰巳光世, Ada Man‐Choi Ho, Ayşegül Özerdem, Alfredo B. Cuéllar‐Barboza, Kaustubh Chavan, Carrie J. Heppelmann, M. Cristine Charlesworth, Deniz Ceylan, Craig A. Stockmeier, Grażyna Rajkowska, Mark A. Frye, Doo‐Sup Choi, Marin Veldić	2020	14
15	Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation Translational Psychiatry ·Charles P. Lewis, John D. Port, Caren J. Blacker, Ayse Irem Sonmez, Bhedita J. Seewoo, Jarrod M. Leffler, Mark A. Frye, Paul E. Croarkin	2020	40
16	Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients Translational Psychiatry ·Sudeepa Bhattacharyya, Garofalo Emanuela, Matthias Arnold, Duan Liu, Chunqiao Luo, Hongjie Zhu, Siamak MahmoudianDehkordi, Drew Neavin, Gregory Louie, Boadie W. Dunlop, Mark A. Frye, Liewei Wang, Richard M. Weinshilboum, Ranga Krishnan, A. John Rush, Rima Kaddurah‐Daouk	2019	62
17	Clinical phenotype and genetic risk factors for bipolar disorder with binge eating: an update Expert Review of Neurotherapeutics ·Alfredo B. Cuéllar‐Barboza, Stacey J. Winham, Joanna M. Biernacka, Mark A. Frye, Susan L. McElroy	2019	4
18	Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta‐analysis of randomized controlled trials Bipolar Disorders ·Nicolás A. Núñez, Balwinder Singh, Francisco Romo‐Nava, Boney Joseph, Marin Veldić, Alfredo B. Cuéllar‐Barboza, 辰巳光世, Jennifer L. Vande Voort, Paul E. Croarkin, Katherine M. Moore, Joanna M. Biernacka, Susan L. McElroy, Mark A. Frye	2019	15
19	Prevalence of axis II comorbidities in bipolar disorder: relationship to mood state Bipolar Disorders ·Robert M. Post, Gabriele S. Leverich, Susan L. McElroy, Ralph Kupka, Trisha Suppes, Lori L. Altshuler, Willem A. Nolen, Mark A. Frye, Paul E. Keck, Heinz Grunze, Gerhard Hellemann	2018	13
20	Testing a clinical staging model for bipolar disorder using longitudinal life chart data Bipolar Disorders ·Francisco González Gómez, Ursula M. H. Klumpers, Stasja Draisma, Annemiek Dols, Willem A. Nolen, Robert M. Post, Lori L. Altshuler, Mark A. Frye, Heinz Grunze, Paul E. Keck, Susan L. McElroy, Trisha Suppes, Aartjan T.F. Beekman, Ralph Kupka	2018	24

About Mark A. Frye

Mark A. Frye is a scholar working on Biological Psychiatry, Psychiatry and Mental health, Speech and Hearing, Pharmacology and Behavioral Neuroscience, having authored 449 papers that have together received 20.4k indexed citations. Recurring topics across this work include Bipolar Disorder and Treatment (293 papers), Electroconvulsive Therapy Studies (82 papers), Treatment of Major Depression (71 papers), Schizophrenia research and treatment (67 papers), Adolescent and Pediatric Healthcare (59 papers), Tryptophan and brain disorders (55 papers), Child and Adolescent Psychosocial and Emotional Development (29 papers) and Mental Health Research Topics (25 papers). The work is most often cited by research in Biological Psychiatry (2.6k citations), Psychiatry and Mental health (13.3k citations), Speech and Hearing (1.6k citations), Pharmacology (3.3k citations) and Clinical Psychology (4.0k citations). Mark A. Frye has collaborated with scholars based in United States, Netherlands and Mexico. Frequent co-authors include Robert M. Post, Susan L. McElroy, Lori L. Altshuler, Gabriele S. Leverich, Paul E. Keck, Ralph Kupka, Willem A. Nolen, Trisha Suppes, Kirk D. Denicoff and Heinz Grunze. Their work appears in journals such as Journal of Affective Disorders, The Journal of Clinical Psychiatry, Bipolar Disorders, Biological Psychiatry and American Journal of Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact